What’s Next? Five Things To Look Out For In May

Teva And Viatris Follow Sandoz On Q1; Key Cabometyx Trial Set To Begin

 
• By Dean Rudge
  
What's Next Image
May's schedule includes Q1 results and a key ANDA trial • Source: Informa

More from Generics

More from Products